Home > Research > Browse

Results for Dose-Response Relationship, Drug

Publications & Outputs

  1. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

    McClean, P. L. & Holscher, C., 11/2014, In : Neuropharmacology. 86, p. 241-258 18 p.

    Research output: Contribution to journalJournal article

  2. Galantamine inhibits β-amyloid aggregation and cytotoxicity

    Matharu, B., Gibson, G., Parsons, R., Huckerby, T. N., Moore, S. A., Cooper, L. J., Millichamp, R., Allsop, D. & Austen, B., 15/05/2009, In : Journal of the Neurological Sciences. 280, 1-2, p. 49-58 10 p.

    Research output: Contribution to journalJournal article